A magnetic bead-based DNA extraction and purification device has been designed to be used for extraction of the target DNA molecules from whole blood sample. Mixing and separation steps are performed using functionalised superparamagnetic beads suspended in the cell lysis buffer in a circular chamber that is sandwiched between two electromagnets. Non-uniform nature of the magnetic field causes temporal and spatial distribution of the beads within the chamber. This process efficiently mixes the lysis buffer and whole blood in order to extract DNA from target cells. Functionalized surface of the magnetic beads then attract the exposed DNA molecules. Finally, DNA-attached magnetic beads are attracted to the bottom of the chamber by activating the bottom electrode. DNA molecules are extracted from the magnetic beads by washing and re-suspension processes. The numerical simulation approach has been adopted in order to design the magnetic field source. The performance of the magnetic field source has been investigated against different physical and geometrical parameters and optimised dimensions are obtained with two different magnetic field sources; integrated internal source and external source. A new magnetic field pattern has been introduced in order to efficiently control the bulk of magnetic beads inside the mixing chamber by dynamic shifting of magnetic field regions from the centre of the coils to the outer edge of the coils and vice versa. A Matlab code has been developed to simulate beads trajectories inside the designed extraction chip in order to investigate the efficiency of the magnetic mixing. A preliminary target molecule capturing simulation has also been performed using the simulated bead trajectories to evaluate the DNA-capturing efficiency of the designed extraction chip. The performance of the designed extraction chip has been tested by conducting a series of biological experiments. Different magnetic bead-based extraction kits have been used in a series of preliminary experiments in order to extract a more automation friendly extraction protocol. The efficiency of the designed device has been evaluated using the spiked bacterial DNA and non-pathogenic bacterial cell cultures (B. subtilis, Gram positive bacteria and E. coli, Gram negative bacteria) into the blood sample. Excellent DNA yields and recovery rates are obtained with the designed extraction chip through a simple and fast extraction protocol.

abstract: Radioactive cesium (137Cs), released from nuclear power plants and nuclear accidental releases, is a problem due to difficulties regarding its removal. Efforts have been focused on removing cesium and the remediation of the contaminated environment. Traditional treatment techniques include Prussian blue and nano zero-valent ion (nZVI) and nano-Fe/Cu particles to remove Cs from water; however, they are not efficient at removing Cs when present at low concentrations of about 10 parts-per-billion (ppb), typical of concentrations found in the radioactive contaminated sites. The objective of this study was to develop an innovative and simple method to remove Cs+ present at low concentrations by engineering a proteoliposome transporter composed of an uptake protein reconstituted into a liposome vesicle. To achieve this, the uptake protein, Kup, from E. coli, was isolated through protein extraction and purification procedures. The new and simple extraction methodology developed in this study was highly efficient and resulted in purified Kup at ~1 mg/mL. A new method was also developed to insert purified Kup protein into the bilayers of liposome vesicles. Finally, removal of CsCl (10 and 100 ppb) was demonstrated by spiking the constructed proteoliposome in lab-fortified water, followed by incubation and ultracentrifugation, and measuring Cs+ with inductively coupled plasma mass spectrometry (ICP-MS). The ICP-MS results from testing water contaminated with 100 ppb CsCl, revealed that adding 0.1 – 8 mL of Kup proteoliposome resulted in 0.29 – 12.7% Cs removal. Addition of 0.1 – 2 mL of proteoliposome to water contaminated with 10 ppb CsCl resulted in 0.65 – 3.43% Cs removal. These removal efficiencies were greater than the control, liposome with no protein. A linear relationship was observed between the amount of proteoliposome added to the contaminated water and removal percentage. Consequently, by adding more volumes of proteoliposome, removal can be simply improved. This suggests that with ~ 60-70 mL of proteoliposome, removal of about 90% can be achieved. The novel technique developed herein is a contribution to emerging technologies in the water and wastewater treatment industry. / Dissertation/Thesis / Doctoral Dissertation Civil, Environmental and Sustainable Engineering 2018

yes / NOM deteriorates water quality by forming taste, clarification, colour, and odour problems. It also increases coagulant and chlorine consumption which can initiate disinfection by-products harmful to human health. The coagulation-flocculation (CF) technique is an established method commonly employed to remove NOM in water treatment. Plant-based coagulant products (PCPs) derived from plants like the Moringa oleifera (MO) Strychnos potatorum Linn and Opuntia ficus indica, have been studied and proposed as sustainable alternatives to chemical coagulant, like, aluminium sulphate due to their abundant availability, low cost, low sludge volume and disposal cost, and biodegradability. This review paper provides an overview of the most widely studied plant-based coagulants and discusses their NOM and turbidity removal. It investigates recent analytical tools applied in their characterisation and floc morphological studies. The paper also investigates the effects of operating parameters such as coagulant dose, temperature, and pH, on NOM and turbidity removal. It also reviews up-to-date PCPs biophysical properties and CF mechanism and examines the efficiency of their extraction methods in reducing NOM. Finally, it discusses and suggests ways to overcome commercialisation draw-back caused by nutrient addition.

L’entreprise SEPROSYS est une société spécialisée dans le développement de solutions d'extraction et de séparation de molécules. Au cours de l’année 2011, l’entreprise a développé un procédé innovant de séparation et de purification fractionnée de biomolécules issues de macroalgues marines. Ce travail de thèse a pour objectif de trouver des applications aux fractions extraites selon le procédé d’extraction et de purification de la société SEPROSYS, et en particulier la fraction des polysaccharides sulfatés, dans deux domaines distincts : en pharmaceutique pour leur activité anti-coagulante et en cosmétique pour leur activité anti-âge. La première partie de nos travaux se penche sur le potentiel des polysaccharides sulfatés de macroalgues comme anti-coagulants. Pour cela, des extraits aqueux de différentes macroalgues brunes, rouges et vertes ont été préparés et leur activité anti-coagulante a été mesurée. Les algues présentant le meilleur potentiel ont ensuite été traitées au moyen du procédé SEPROSYS® afin de purifier leurs polysaccharides sulfatés et d’étudier leur activité anti-coagulante. De plus, l’objectif de ce travail consiste également à mieux comprendre la relation structure-fonction de l'activité anticoagulante d'ulvanes. A cette fin, des ulvanes issus d’Ulva sp. de pureté élevée ont été produits par le procédé SEPROSYS®, soumis à des modifications chimique (hypersulfatation) et physique (dépolymérisation) et leur activité anticoagulante a été étudiée. La deuxième partie de nos travaux concerne l’évaluation du potentiel de ces macroalgues comme agents actifs utilisables en dermo-cosmétique, en particulier pour leur activité anti-âge. Dans ce but, différentes fractions de macroalgues brunes, rouges et vertes ont été testées sur des lignées cellulaires de fibroblastes dermiques humains et leur effet sur la production de collagène par ces fibroblastes a été étudié. Enfin, le potentiel d’ulvanes extraits d’Uva sp. par le procédé de l’entreprise SEPROSYS pour stimuler la biosynthèse de collagène et d’acide hyaluronique par ces mêmes fibroblastes a été déterminé. / SEPROSYS is a company specialized in the development of solutions for the extraction and separation of molecules. In 2011, the company has developed an innovative process of fractionated separation and purification of biomolecules from macroalgae. The purpose of this thesis work is to find applications for the purified fractions from the SEPROSYS® process and in particular the sulfated polysaccharides, for two distinct biological activities : as pharmaceutical for their anti-coagulant activity and as dermo-cosmetics for their anti-aging activity. The first part of our work focus on the potential of sulfated polysaccharides from macroalgae as anti-coagulant agents. To this end, aqueous extracts from brown, red and green macroalgae were prepared and their anti-coagulant activity was measured. The best macroalgae were then processed with the SEPROSYS procedure in order to purify the sulfated polysaccharides and study their activity. Furthermore, one of the objectives of this work was to acquire a better understanding of the structure/anti-coagulant function relationship of ulvans. Ulvans of high purity were extracted from Ulva sp. with the SEPROSYS® process, submitted to chemical (hypersulfatation) and physical (depolymerization) modifications and their anti-coagulant activity was measured. The second part of our work relates to the potential of the macroalgae as active agents to be used in dermo-cosmetics, and, in particular, for their anti-aging activity. Different brown, red and green macroalgae fractions were thus tested on normal human dermal fibroblasts cell lines and their effects on the collagen production were measured. Furthermore, the capacity of different molecular weight ulvans extracted from Ulva sp. to stimulate the collagen and hyaluronan biosynthesis was studied. To this end, we developed an efficient depolymerization procedure using ion exchange resins.